Skip to main content

Hairy Cell Leukemia News

Related terms: Cancer, Hairy Cell Leukemia, Leukemia, Hairy Cell, Leukemic reticuloendotheliosis, HCL

FDA Approves Lumoxiti (moxetumomab pasudotox-tdfk) for Hairy Cell Leukemia

September 13, 2018 – The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Leukemia